弥漫性血管内凝血(DIC)是一个多种致病因素引起的复杂中间病理过程。其特征是血液凝血酶增加,血液处于高凝状态,引起循环内广泛血栓形成,因而消耗大量凝血因子及血小板,使血液从高凝状态转化为低凝状态,继发纤维蛋白溶解出血,随之发生更严重的器官功能障碍和组织坏死。为阻止上述病理过程的发展,除治疗原发病外.在早期投予肝素治疗,以抑制凝血酶的产生,抑制血 Diffuse intravascular coagulation (DIC) is a complex intermediate pathological process caused by a variety of pathogenic factors. It is characterized by increased blood thrombin, hypercoagulable state in the blood, causing extensive thrombosis within the circulation, which consumes a large number of coagulation factors and platelets, the blood from hypercoagulable state into a low coagulation state, secondary fibrinolysis bleeding, followed More severe organ dysfunction and tissue necrosis occur. In order to prevent the development of the pathological process, in addition to the treatment of primary disease in the early administration of heparin to inhibit the production of thrombin, inhibition of blood